Soares A, Garcia-Rivas V, Fai C, Thomas M, Zheng X, Picciotto M
Biol Sex Differ. 2025; 16(1):19.
PMID: 40038827
PMC: 11881309.
DOI: 10.1186/s13293-025-00701-y.
Shrivastava P, Lu Y, Su S, Kobayashi Y, Zhao Y, Lien N
Biomedicines. 2025; 12(12.
PMID: 39767773
PMC: 11673747.
DOI: 10.3390/biomedicines12122865.
Lopez A, Chirasani V, Balan I, OBuckley T, Adelman M, Morrow A
Biomolecules. 2024; 14(11).
PMID: 39595617
PMC: 11591752.
DOI: 10.3390/biom14111441.
Clark S, Hartwell E, Choi D, Krystal J, Messing R, Ferguson L
Alcohol Clin Exp Res (Hoboken). 2024; 49(1):5-24.
PMID: 39532676
PMC: 11747793.
DOI: 10.1111/acer.15476.
Yang Y, Rao T, Wei S, Cheng J, Zhan Y, Lin T
Front Microbiol. 2024; 15:1398618.
PMID: 39247699
PMC: 11380139.
DOI: 10.3389/fmicb.2024.1398618.
A systematic review and meta-analysis on the transcriptomic signatures in alcohol use disorder.
Friske M, Torrico E, Haas M, Borruto A, Giannone F, Hade A
Mol Psychiatry. 2024; 30(1):310-326.
PMID: 39242950
PMC: 11649567.
DOI: 10.1038/s41380-024-02719-x.
Region-Specific Gene Expression Changes Associated with Oleoylethanolamide-Induced Attenuation of Alcohol Self-Administration.
Gonzalez-Portilla M, Montagud-Romero S, Mellado S, Rodriguez de Fonseca F, Pascual M, Rodriguez-Arias M
Int J Mol Sci. 2024; 25(16).
PMID: 39201687
PMC: 11354326.
DOI: 10.3390/ijms25169002.
Alcohol, HMGB1, and Innate Immune Signaling in the Brain.
Crews F, Coleman Jr L, Macht V, Vetreno R
Alcohol Res. 2024; 44(1):04.
PMID: 39135668
PMC: 11318841.
DOI: 10.35946/arcr.v44.1.04.
Sex-specific effects of alcohol on neurobehavioral performance and endoplasmic reticulum stress: an analysis using neuron-specific MANF deficient mice.
Wen W, Li H, Lauffer M, Hu D, Zhang Z, Lin H
Front Pharmacol. 2024; 15:1407576.
PMID: 39130640
PMC: 11310019.
DOI: 10.3389/fphar.2024.1407576.
Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment.
Karatayev O, Collier A, Targoff S, Leibowitz S
Int J Mol Sci. 2024; 25(15).
PMID: 39125913
PMC: 11313660.
DOI: 10.3390/ijms25158341.
Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder.
Grodin E, McManus K, Ray L
Addict Biol. 2024; 29(8):e13431.
PMID: 39091190
PMC: 11294675.
DOI: 10.1111/adb.13431.
The crosstalk between fibroblast growth factor 21 (FGF21) system and substance use.
Wang T, Tyler R, Ilaka O, Cooper D, Farokhnia M, Leggio L
iScience. 2024; 27(7):110389.
PMID: 39055947
PMC: 11269927.
DOI: 10.1016/j.isci.2024.110389.
Biological basis of addiction and alcohol use disorder.
Tyler R, Leggio L
Clin Liver Dis (Hoboken). 2024; 23(1):e0177.
PMID: 38831763
PMC: 11146604.
DOI: 10.1097/CLD.0000000000000177.
Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders.
Balan I, Boero G, Chery S, McFarland M, Lopez A, Morrow A
Life (Basel). 2024; 14(5).
PMID: 38792602
PMC: 11122352.
DOI: 10.3390/life14050582.
Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study.
Rodriguez de Fonseca F, Medina-Paz F, Sapozhnikov M, Hurtado-Guerrero I, Rubio L, Martin-de-Las-Heras S
Toxics. 2024; 12(3).
PMID: 38535924
PMC: 10974976.
DOI: 10.3390/toxics12030190.
Neuroimmune modulators as novel pharmacotherapies for substance use disorders.
Grodin E
Brain Behav Immun Health. 2024; 36:100744.
PMID: 38435721
PMC: 10906159.
DOI: 10.1016/j.bbih.2024.100744.
Alcohol use and the pain system.
Vigorito M, Chang S
Adv Drug Alcohol Res. 2024; 4:12005.
PMID: 38389900
PMC: 10880763.
DOI: 10.3389/adar.2024.12005.
Alcohol induced behavioral and immune perturbations are attenuated by activation of CB2 cannabinoid receptors.
Roberts A, Christian M, Dilone L, Nelson N, Endrino M, Kneebone A
Adv Drug Alcohol Res. 2024; 3:11602.
PMID: 38389814
PMC: 10880753.
DOI: 10.3389/adar.2023.11602.
Microglia activity in the human basal ganglia is altered in alcohol use disorder and reversed with remission from alcohol.
Rasool A, Furlong T, Prasad A
Addict Biol. 2024; 29(2):e13374.
PMID: 38380734
PMC: 10898843.
DOI: 10.1111/adb.13374.
A reverse translational study of PPAR-α agonist efficacy in human and rodent models relevant to alcohol use disorder.
Mason B, Estey D, Roberts A, de Guglielmo G, George O, Light J
Neurobiol Stress. 2024; 29:100604.
PMID: 38292518
PMC: 10825428.
DOI: 10.1016/j.ynstr.2023.100604.